Altimmune, Inc. (ALT)
4.80
+0.18
(+3.90%)
USD |
NASDAQ |
Jan 22, 12:07
Altimmune Total Assets (Annual): 139.31M for Dec. 31, 2024
Total Assets (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Annual) Benchmarks
| Viking Therapeutics, Inc. | 908.32M |
| CorMedix, Inc. | 118.85M |
| Actinium Pharmaceuticals, Inc. | 76.90M |
| Aldeyra Therapeutics, Inc. | 104.61M |
| Seres Therapeutics, Inc. | 139.81M |